Polaris AI Pharma Corp. (KOSDAQ:041910)
South Korea · Delayed Price · Currency is KRW 6,460.00
-180.00 (-2.71%)
At close: Feb 13, 2026
Polaris AI Pharma Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
Period Ending | Sep '22 Sep 30, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Operating Revenue | 63,935 | 60,401 | 61,324 | 46,490 | 40,336 | 38,214 |
Other Revenue | -0 | - | - | - | - | 0 |
| 63,935 | 60,401 | 61,324 | 46,490 | 40,336 | 38,214 | |
Revenue Growth (YoY) | 8.69% | -1.50% | 31.91% | 15.26% | 5.55% | -11.94% |
Cost of Revenue | 51,063 | 46,617 | 43,991 | 33,541 | 30,536 | 27,159 |
Gross Profit | 12,872 | 13,784 | 17,333 | 12,948 | 9,800 | 11,054 |
Selling, General & Admin | 6,151 | 5,888 | 5,484 | 5,266 | 4,338 | 4,504 |
Research & Development | 2,964 | 3,194 | 3,301 | 3,281 | 3,567 | 3,287 |
Amortization of Goodwill & Intangibles | 48.76 | 46.82 | 60.79 | 90.18 | 125.66 | 149.84 |
Other Operating Expenses | 195.31 | 176.47 | 170.64 | 188.87 | 116.02 | 143.66 |
Operating Expenses | 9,711 | 9,578 | 9,099 | 9,220 | 8,250 | 8,187 |
Operating Income | 3,161 | 4,205 | 8,234 | 3,728 | 1,550 | 2,867 |
Interest Expense | -21.85 | -6.28 | -11.2 | -16.13 | -88.83 | -223.97 |
Interest & Investment Income | 459.88 | 328.61 | 429.25 | 520.1 | 267.86 | 96.72 |
Earnings From Equity Investments | -296.96 | 2,362 | 156.36 | - | - | - |
Currency Exchange Gain (Loss) | 186.99 | 773.33 | -591.14 | 986.19 | 847.02 | -1,827 |
Other Non Operating Income (Expenses) | 378.85 | 345.05 | 78.61 | 231.48 | 442.57 | -43.66 |
EBT Excluding Unusual Items | 3,868 | 8,008 | 8,295 | 5,450 | 3,018 | 868.95 |
Gain (Loss) on Sale of Investments | -3,672 | -288.7 | 12,098 | 13,622 | 4,942 | 1,854 |
Gain (Loss) on Sale of Assets | 61.13 | 53.58 | 17.71 | -16.07 | 4.42 | -6.62 |
Asset Writedown | - | - | -1,020 | - | - | - |
Pretax Income | 256.35 | 7,773 | 19,391 | 19,056 | 7,965 | 2,717 |
Income Tax Expense | -733.13 | 898.21 | 3,659 | 3,828 | 1,375 | -9.42 |
Net Income | 989.48 | 6,875 | 15,733 | 15,228 | 6,590 | 2,726 |
Net Income to Common | 989.48 | 6,875 | 15,733 | 15,228 | 6,590 | 2,726 |
Net Income Growth | -92.80% | -56.30% | 3.31% | 131.09% | 141.71% | -34.27% |
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 |
Shares Change (YoY) | - | - | - | -1.33% | 1.60% | -1.97% |
EPS (Basic) | 84.72 | 588.60 | 1346.96 | 1303.77 | 564.67 | 237.00 |
EPS (Diluted) | 84.72 | 588.60 | 1346.96 | 1303.77 | 557.00 | 234.00 |
EPS Growth | -92.80% | -56.30% | 3.31% | 134.07% | 138.03% | -32.95% |
Free Cash Flow | -4,694 | -1,395 | 2,510 | 3,165 | 6,784 | 6,298 |
Free Cash Flow Per Share | -401.90 | -119.41 | 214.91 | 270.94 | 573.07 | 540.59 |
Dividend Per Share | 100.000 | 100.000 | 100.000 | 100.000 | 50.000 | - |
Dividend Growth | - | - | - | 100.00% | - | - |
Gross Margin | 20.13% | 22.82% | 28.27% | 27.85% | 24.30% | 28.93% |
Operating Margin | 4.94% | 6.96% | 13.43% | 8.02% | 3.84% | 7.50% |
Profit Margin | 1.55% | 11.38% | 25.66% | 32.76% | 16.34% | 7.13% |
Free Cash Flow Margin | -7.34% | -2.31% | 4.09% | 6.81% | 16.82% | 16.48% |
EBITDA | 5,778 | 6,879 | 10,908 | 6,475 | 4,288 | 6,583 |
EBITDA Margin | 9.04% | 11.39% | 17.79% | 13.93% | 10.63% | 17.23% |
D&A For EBITDA | 2,617 | 2,674 | 2,675 | 2,747 | 2,738 | 3,716 |
EBIT | 3,161 | 4,205 | 8,234 | 3,728 | 1,550 | 2,867 |
EBIT Margin | 4.94% | 6.96% | 13.43% | 8.02% | 3.84% | 7.50% |
Effective Tax Rate | - | 11.55% | 18.87% | 20.09% | 17.27% | - |
Advertising Expenses | - | 76.42 | 92.28 | 272.03 | 278.89 | 264.45 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.